Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | EVP, AMEA | August 08, 2025 | August 12, 2025 |
| Tempest Therapeutics, Inc.OVAS · Entity 7734 | Chief Financial Officer | December 23, 2016 | March 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date August 08, 2025 · Filed August 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 211,271 |
Reported balance
After 2025-08-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-08-08 · Grant · Acquired 65,217 · Balance 211,271 F1: Reflects a grant of restricted stock units that vest on August 8, 2027. F2: Includes 1,140 shares acquired under the Avantor Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vest on August 8, 2027.
F2: Includes 1,140 shares acquired under the Avantor Employee Stock Purchase Plan.
Tempest Therapeutics, Inc.
Report date December 23, 2016 · Filed March 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 50,900 |
Reported balance
After 2016-12-23 transaction · row 1
1 source rowRow 1 · 2016-12-23 · Grant · Acquired 300 · Balance 50,900 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2021 Filed Dec 10, 2021 17:00 UTC | Avantor, Inc. AVTR · Entity 3546 | Exercise / conversionCommon Stock | 7,859 | $17.67 | $138,868.53 |
DisclosureSEC source: 0001722482-21-000271 · wf-form4_163917364274792.xml · nonDerivative · entry 3 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 17:00 UTC | Avantor, Inc. AVTR · Entity 3546 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,828 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0001722482-21-000271 · wf-form4_163917364274792.xml · derivative · entry 5 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,917 Underlying: Common Stock · 5,828 shares Expires 2028-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects an initial grant of 54,745 stock options that vest in four equal installments beginning on February 21, 2021. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 17:00 UTC | Avantor, Inc. AVTR · Entity 3546 | SaleCommon Stock | 5,828 | $40.00 | $233,120.00 |
DisclosureSEC source: 0001722482-21-000271 · wf-form4_163917364274792.xml · nonDerivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,497 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person herein. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 17:00 UTC | Avantor, Inc. AVTR · Entity 3546 | Exercise / conversionCommon Stock | 5,828 | $17.67 | $102,980.76 |
DisclosureSEC source: 0001722482-21-000271 · wf-form4_163917364274792.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 420 shares acquired under the Avantor Employee Stock Purchase Plan. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 17:11 UTC | Avantor, Inc. AVTR · Entity 3546 | SaleCommon Stock | 28,096 | $35.73 | $1,003,870.08 |
DisclosureSEC source: 0001722482-21-000186 · wf-form4_162500109958073.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,077 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person herein. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $35.55 to $35.87, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| May 20, 2021 Filed May 21, 2021 16:55 UTC | Avantor, Inc. AVTR · Entity 3546 | SaleCommon Stock | 25,010 | $31.13 | $778,561.30 |
DisclosureSEC source: 0001722482-21-000161 · wf-form4_162163050256475.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,173 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person herein. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.945 to $31.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| May 17, 2021 Filed May 19, 2021 17:14 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 14,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000146 · wf-form4_162145883330238.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,183 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 17:52 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 8,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000105 · wf-form4_161783234899051.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,459 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on April 5, 2022. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 17:32 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 21,956 | $0.00 Strike: $27.64 | $0.00 |
DisclosureSEC source: 0001722482-21-000090 · wf-form4_161463791486976.xml · derivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,956 Underlying: Common Stock · 21,956 shares Expires 2031-02-25 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 25, 2022. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 17:32 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 6,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-21-000090 · wf-form4_161463791486976.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,192 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 25, 2022. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 17:50 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 1,313 | $28.69 | $37,669.97 |
DisclosureSEC source: 0001722482-21-000053 · wf-form4_161412059067162.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,408 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. F2 · balance_after: Includes 789 shares acquired under the Avantor Employee Stock Purchase Plan. Read SEC document |
| May 17, 2020 Filed May 19, 2020 18:53 UTC | Avantor, Inc. AVTR · Entity 3546 | Tax withholdingCommon Stock | 11,189 | $17.86 | $199,835.54 |
DisclosureSEC source: 0001722482-20-000118 · wf-form4_158992880632422.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,932 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:42 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantStock Options (Right to Buy) · Derivative | 54,745 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0001722482-20-000057 · wf-form4_158267050959628.xml · derivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,745 Underlying: Common Stock · 54,745 shares Expires 2030-02-21 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 21, 2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 17:42 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 16,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-20-000057 · wf-form4_158267050959628.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,121 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 21, 2021. Read SEC document |
| May 21, 2019 Filed May 23, 2019 19:30 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 157,143 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-014605 · doc4.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,143 F1 · kind: Reflects a grant of restricted stock units that vests as follows: (a) 50% vests on May 21, 2021, and (b) the remaining 50% vests in two equal annual installments beginning on May 21, 2022. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 20:07 UTC | Tempest Therapeutics, Inc. OVAS · Entity 7734 | GrantStock Option (right to buy) · Derivative | 45,750 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001179110-17-004065 · edgar.xml · derivative · entry 1 Couturier Christophe · CIK 0001684076 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,750 Underlying: Common Stock · 45,750 shares Expires 2027-03-02 F1 · derivative.exercise_date: The option vests as to 25% of the option shares on March 2, 2018 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter until March 2, 2021. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 19:36 UTC | Tempest Therapeutics, Inc. OVAS · Entity 7734 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001179110-17-000824 · edgar.xml · derivative · entry 1 Couturier Christophe · CIK 0001684076 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-01-05 F1 · derivative.exercise_date: The option vests as to 12.5% of the option shares on January 5, 2017 and vests as to an additional 12.5% of the option shares at the end of each successive three-month period thereafter. Read SEC document |
| December 23, 2016 Filed Mar 13, 2017 21:21 UTC | Tempest Therapeutics, Inc. OVAS · Entity 7734 | GrantCommon Stock | 300 | $1.44 | $431.16 |
DisclosureSEC source: 0001179110-17-004542 · edgar.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,900 Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 19:15 UTC | Tempest Therapeutics, Inc. OVAS · Entity 7734 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001179110-16-029578 · edgar.xml · derivative · entry 2 Couturier Christophe · CIK 0001684076 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2026-09-08 F3 · derivative.exercise_date: The option vests as to 25% of the option shares on September 6, 2017 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 19:15 UTC | Tempest Therapeutics, Inc. OVAS · Entity 7734 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-029578 · edgar.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,600 F1 · shares: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting. The RSU vests as to 25% of the shares on September 6, 2017 and as to an additional 6.25% of the shares each successive three-month period thereafter, until September 6, 2020. F2 · balance_after: Represents 600 shares of common stock and 50,000 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.